One of Hottest for Dapoxetine Hcl - High Purity 366789-02-8 Rivaroxaban for Treatment of Adult Venous Thrombosis – Yibai
One of Hottest for Dapoxetine Hcl - High Purity 366789-02-8 Rivaroxaban for Treatment of Adult Venous Thrombosis – Yibai Detail:
Product name | Rivaroxaban |
Synonyms | 5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide |
CAS No. | 366789-02-8 |
Appearance | White powder |
Molecular Formula | C19H18ClN3O5S |
Molecular Weight | 435.88 |
Application | Pharmaceutical grade or research purpose |
Packing | As per your request |
Storage | Preserve in tight,light-resistant containers in a cool place |
Company Information
√ Management layer’s full experience in factory and skilled technicians followers; √ Quality is always our top consideration, Strict QC system; √ 11 years experienced exporting sales team; √ Independent R&D lab; √ Two signed long term GMP workshops; √ Rich resources of plenty idle factories for customized project; √ High Efficiency working team with consistent path.Product detail pictures:
Related Product Guide:
We constantly function like a tangible group to ensure that we can give you the very best high-quality and also the very best cost for One of Hottest for Dapoxetine Hcl - High Purity 366789-02-8 Rivaroxaban for Treatment of Adult Venous Thrombosis – Yibai , The product will supply to all over the world, such as: Hamburg, Puerto Rico, Finland, Many kinds of different solutions are available for you to choose, you can do one-stop shopping here. And customized orders are acceptable. Real business is to get win-win situation, if possible, we would like to deliver more support for customers. Welcome all nice buyers communicate details of solutions with us!!
By Hazel from Atlanta - 2018.12.11 14:13
The customer service reprersentative explained very detailed, service attitude is very good, reply is very timely and comprehensive, a happy communication! We hope to have a opportunity to cooperate.
By Judy from Johannesburg - 2017.04.18 16:45
Write your message here and send it to us